166 related articles for article (PubMed ID: 36518090)
21. Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges.
Sato D; Takami H; Takayanagi S; Taoka K; Tanaka M; Matsuura R; Tanaka S; Saito N
BMC Neurol; 2023 Jun; 23(1):224. PubMed ID: 37296412
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
23. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
24. Primary central nervous system other iatrogenic immunodeficiency-associated lymphoproliferative disorders presenting as extraosseous plasmacytoma with a progressive clinical course: A case report and literature review.
Ohgaki F; Takemoto Y; Paku S; Tatezuki J; Kumagai J; Shuto T; Mochimatsu Y
Neuropathology; 2023 Apr; 43(2):151-157. PubMed ID: 36065518
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
Moriya K; Kikuti YY; Carreras J; Kondo Y; Shiraiwa S; Nakamura N
J Clin Exp Hematop; 2020; 60(1):11-16. PubMed ID: 32224560
[TBL] [Abstract][Full Text] [Related]
26. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
27. Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings.
Wada S; Suzuki T; Kitazume K; Fujita A; Shimizu S
Int J Hematol; 2018 Jul; 108(1):112-117. PubMed ID: 29218495
[TBL] [Abstract][Full Text] [Related]
28. Immunomodulator agent-related lymphoproliferative disorders.
Hasserjian RP; Chen S; Perkins SL; de Leval L; Kinney MC; Barry TS; Said J; Lim MS; Finn WG; Medeiros LJ; Harris NL; O'Malley DP
Mod Pathol; 2009 Dec; 22(12):1532-40. PubMed ID: 19767727
[TBL] [Abstract][Full Text] [Related]
29. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
[TBL] [Abstract][Full Text] [Related]
30. Age-related Epstein-Barr Virus-associated Lymphoproliferative Disorder Masquerading as Systemic Lupus Erythematosus.
Kadoba K; Nishimura K; Uchino K; Waki D; Murabe H; Yokota T
Intern Med; 2021 Aug; 60(15):2495-2497. PubMed ID: 33583902
[TBL] [Abstract][Full Text] [Related]
31. [Iatrogenic immunodeficiency-associated Epstein-Barr virus (EBV) -negative natural killer cell lymphoproliferative disorder in a patient undergoing rheumatoid arthritis therapy].
Uchida T; Inoue M; Hua J; Tajima S; Ota Y; Hagihara M
Rinsho Ketsueki; 2017; 58(6):624-629. PubMed ID: 28679993
[TBL] [Abstract][Full Text] [Related]
32. Polymorphous lymphoproliferative disorder: a clinicopathological analysis.
Nakamichi N; Wada N; Kohara M; Fukuhara S; Sugiyama H; Ogawa H; Hino M; Kanamaru A; Kanakura Y; Morii E; Aozasa K
Virchows Arch; 2010 Mar; 456(3):269-76. PubMed ID: 20111873
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and Outcomes of Alberta Lymphoma Patients with a History of Immunosuppressive therapy for Autoimmune Conditions.
Kantharia K; Owen C; Stewart D; Yau P; Ghosh S; Dersch-Mills D
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):894-902. PubMed ID: 36031543
[TBL] [Abstract][Full Text] [Related]
34. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
Satou A; Tabata T; Suzuki Y; Sato Y; Tahara I; Mochizuki K; Oishi N; Takahara T; Yoshino T; Tsuzuki T; Nakamura S
Virchows Arch; 2021 May; 478(5):969-976. PubMed ID: 33169195
[TBL] [Abstract][Full Text] [Related]
35. A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study.
Ambrosio MR; Rocca BJ; Ginori A; Mourmouras V; Amato T; Vindigni C; Lazzi S; Leoncini L
Am J Clin Pathol; 2015 Nov; 144(5):817-22. PubMed ID: 26486748
[TBL] [Abstract][Full Text] [Related]
36. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Kawabe S; Ito Y; Gotoh K; Kojima S; Matsumoto K; Kinoshita T; Iwata S; Nishiyama Y; Kimura H
Cancer Sci; 2012 Aug; 103(8):1481-8. PubMed ID: 22497716
[TBL] [Abstract][Full Text] [Related]
37. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.
Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974
[TBL] [Abstract][Full Text] [Related]
38. The first autopsy case of Epstein-Barr virus-positive marginal zone lymphoma that deteriorated after COVID-19 vaccination.
Wang Z; Muto R; Miyoshi H; Aoki M; Uesugi N; Murayama H; Masutani K; Hamasaki M
Pathol Int; 2024 Feb; 74(2):87-92. PubMed ID: 38116849
[TBL] [Abstract][Full Text] [Related]
39. Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin.
Chai C; White WL; Shea CR; Prieto VG
J Cutan Pathol; 1999 May; 26(5):242-7. PubMed ID: 10408349
[TBL] [Abstract][Full Text] [Related]
40. Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia.
Menter T; Schlageter M; Bastian L; Haberthür R; Rätz Bravo AE; Tzankov A
Hematol Oncol; 2014 Mar; 32(1):47-51. PubMed ID: 23625339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
